Table 8. Enriched pathway or disease returned by DAVID.

k	Gene name	Pathway or disease
10	DUSP10	MAPK (Mascall et al., 2012)
	SH2D4A	Angiogenesis, VEGF (Mascall et al., 2012; Qiu et al., 2014b)
8, 9	BCL2L1	Ras (Lan et al., 2010)
	CTGF	Cardiovascular disease
	HSPA1A	Restenosis
	PLAU	Blood coagulation
7	BCL2L1	Ras (Lan et al., 2010; Mascall et al., 2012)
	BDKRB1	Cardiovascular disease
	CCL2	Cardiovascular disease
	CTGF	Cardiovascular disease
	CDKN1B	Cardiovascular disease
	DDB2	p53 (Dardik et al., 2005; Wójtowicz et al., 2010)
	DLC1	PDGF (Hurley et al., 2010; Smyth, 2005)
	FAM13A	Angiogenesis
	HSPA1A	Restenosis
	IGF1R	IGF1R (Arcaro & Guerreiro, 2007; Huang et al., 2014; Jacob et al., 2005; Sebolt-Leopold & Herrera, 2004)
	MED20	Gene expression (Boehm & Nabel, 2001)
	NFIB	Cellular process (Qiu et al., 2014a)
	NR1D1	NFkB (Qiu et al., 2014a)
	NR4A1	MAPK (Hinze et al., 2013)
	PMAIP1	p53 (Dardik et al., 2005; Wójtowicz et al., 2010)
	PLAU	Blood coagulation
	TCF4	Cellular process (Fitzgerald et al., 2008)

Note:

Bold-faced gene name denote new putative genes identified by cluster analysis; they were not found by differential expression or topological analysis.